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Strengths and limitations of this study
 ► Robust consensus methodology and transparent 
reporting was used to allow public scrutiny of all 
information included or excluded from the core in-
formation set.
 ► Patient and professional views were given equal 
weighting in the consensus process.
 ► The patient response rate was low, however, pur-
posive sampling ensured representation of key 
demographics.
AbStrACt
Objective ‘Core information sets’ (CISs) represent 
baseline information, agreed by patients and professionals, 
to stimulate individualised patient- centred discussions. 
This study developed a CIS for use before colorectal 
cancer (CRC) surgery.
Design Three phase consensus study: (1) Systematic 
literature reviews and patient interviews to identify 
potential information of importance to patients, (2) UK 
national Delphi survey of patients and professionals to 
rate the importance of the information, (3) international 
consensus meeting to agree on the final CIS.
Setting UK CRC centres.
Participants Purposive sampling was conducted 
to ensure CRC centre representation based upon 
geographical region and caseload volume. Responses were 
received from 63/81 (78%) centres (90 professionals). 
Adult patients who had undergone CRC surgery were 
eligible, and purposive sampling was conducted to ensure 
representation based on age, sex and cancer location 
(rectum, left and right colon). Responses were received 
from 97/267 (35%) patients with a wide age range (29–
87), equal sex ratio and cancer location. Attendees of the 
international Tripartite Colorectal Conference were eligible 
for the consensus meeting.
Outcomes Phase 1: Information of potential importance to 
patients was extracted verbatim and operationalised into a 
Delphi questionnaire. Phase 2: Patients and professionals 
rated the importance information on a 9- point Likert scale, 
and resurveyed following group feedback. Information 
rated of low importance were discarded using predefined 
criteria. Phase 3: A modified nominal group technique 
was used to gain final consensus in separate consensus 
meetings with patients and professionals.
results Data sources identified 1216 pieces of 
information that informed a 98- item questionnaire. 
Analysis led to 50 and 23 information domains being 
retained after the first and second surveys, respectively. 
The final CIS included 11 concepts including specific 
surgical complications, short and long- term survival, 
disease recurrence, stoma and quality of life issues.
Conclusions This study has established a CIS for 
professionals to discuss with patients before CRC surgery.
IntrODuCtIOn
High- quality, patient- centred communication 
is a cornerstone of clinical practice in the 
UK and worldwide.1–4 Such communication 
can facilitate shared decision- making, where 
doctors and patients agree on a treatment plan 
that best fits the patient’s needs, and ensure 
that patients’ fundamental ethical right to 
self- determination is maintained through 
the process of informed consent (IC).5 This 
is particularly important in surgical oncology. 
For many patients with cancer, surgery offers 
the best chance of long- term survival but 
this must be balanced against short term 
mortality and potentially irreversible deterio-
ration in quality of life. Understanding and 
weighing- up the nature and consequences of 
treatment, based on personal values, is there-
fore an important part of the cancer journey.
There are, however, significant challenges 
in addressing the information needs of indi-
vidual patients. The amount of information 
that could be discussed is vast, and it is unclear 
what information is critical to inform under-
standing in an individual. Generally, patients 
prefer more rather than less information,6 but 
there is a danger of overwhelming patients 
with information that is not important to 
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them, and this may reduce understanding and increase 
anxiety.7 ‘Important’ information is itself subjective, and 
what is important to one person may not be to another. 
This includes information that may or may not be relevant 
to the nature and consequences of the proposed surgery. 
Patient- led communication, where discussions are guided 
by the individual, is helpful but patients may lack suffi-
cient baseline knowledge to ask important questions.
Beyond these professional and ethical responsibilities, 
there are additional requirements to meet legal standards 
of information provision for IC. There has been a gradual 
shift away from a physician- centred, paternalistic model 
of consent towards a ‘reasonable- patient’ standard.5 This 
aligns the process of IC to the patients’ perspective, and 
requires surgeons to discuss all relevant information about 
a proposed treatment that an objective patient would find 
material to making an informed decision. This model has 
been endorsed through the recent Montgomery ruling in 
the UK, and is common in other jurisdictions,8 but it is at 
once confusing and helpful in addressing patients’ infor-
mation needs.9 On the one hand, it is a somewhat abstract 
concept that does little to help physicians tailor informa-
tion to the individual.10 Without a clear understanding 
of who a reasonable patient might be, the temptation 
exists to over disclose. On the other hand, the reasonable- 
patient standard might serve best if viewed as a baseline 
from which more meaningful, person- centred conversa-
tions develop.
One method for balancing over and under disclo-
sure of information is to develop a ‘core information 
set’ (CIS) for a specific treatment. Core information 
represents baseline information, determined by patients 
and clinicians, necessary to stimulate further patient- 
centred communication.11–14 A CIS is intended for use 
once a treatment recommendation or decision has been 
made and will provide relevant information about a single 
intervention. This differs from the role and purpose of 
a decision aid which deliberately provides information 
about alternative treatment choices.15 It has the advan-
tages of being feasible and transferable to a wide number 
of settings, possible to define using established health 
services research methodology, aligned with contempo-
rary ethical theory, and potentially meeting the ‘reason-
able patient’ legal standard of IC. CISs are available for 
oesophageal and oropharyngeal cancers.12 16
The aim of this study is to define a CIS for colorectal 
cancer (CRC) surgery. CRC is the third most common 
cancer in men and second most common in women 
worldwide, with an estimated incidence over 740 000 and 
610 000, respectively.17 The majority of these patients will 
undergo a surgical resection and methods are therefore 
needed to ensure that IC is optimised.
MethODS
Study design
This study was conducted in three phases using methods 
modified from the development of core outcome sets for 
randomised controlled trials18: (1) a long- list of poten-
tial information of importance before CRC surgery was 
identified and categorised into domains, (2) domains 
were operationalised into a questionnaire that was used 
to survey stakeholders’ views on the importance of each 
domain using Delphi methods, (3) consensus meetings 
with patients and professionals were used to finalise the 
CIS.
This study was conducted in parallel with the develop-
ment of a set of outcomes to measure in CRC randomised 
trials, the results of which are published elsewhere.19 The 
same study population was used to concurrently address 
this separate research question. It was hypothesised that 
there may be observed differences between the core 
outcome and information sets as they are conceptually 
different.
Phase 1: Domain generation
Information about CRC surgery was identified from 
systematic reviews of clinical and patient reported 
outcome literature (published elsewhere),20 21 supple-
mented by a review of patient information leaflets and 
interviews with patients to identify additional information 
not present in the published literature.
An information long- list was created, and similar infor-
mation was categorised into domains by two members 
of the study team and a patient representative. The 
final domains were operationalised into questionnaire 
items using lay language, and piloted by patients for face 
validity, understanding and acceptability.
Phase 2: Delphi consensus process
The questionnaire was sent to key stakeholders (CRC 
surgeons, specialist nurses and patients who had under-
gone surgery for CRC). Patients were essential stake-
holders as they are the recipient of treatment, and 
surgeons and nurses have an in- depth understanding of 
the potential impact of surgery. Family, carers and friends 
were not included because, although these people form 
part of clinical discussions, IC is the prerogative of an 
autonomous individual. Participants were welcome to 
consult with others when considering the importance of 
information domains.
Professionals were identified from UK National 
Health Service hospital trusts that participated in the UK 
National Bowel Cancer Audit. Non- probabilistic purpo-
sive sampling was conducted to ensure centre variation 
based on geographical region (Northern England, the 
Midlands, South West and South East England, and 
Wales), and caseload volume. Patients were recruited 
from University Hospitals Bristol NHS Foundation Trust, 
North Bristol NHS Trust and Plymouth Hospitals NHS 
trust. Participants were approached by post from partici-
pating centres and sent a participant information leaflet, 
a consent form and the questionnaire with a stamp 
addressed return envelope. Non- probabilistic purposive 
sampling was conducted to ensure representation based 
on age, sex and cancer site (rectum, left colon, right 
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Figure 1 Questionnaire front sheet. CRC, colorectal cancer.
colon). Demographic data, including area of deprivation, 
marital status, employment status, educational level, were 
collected. Deprivation was as defined by the UK Office of 
National Statistics Index of Multiple Deprivation at lower 
layer Super Output Area level for the individual.22 This is 
a combined measure of income, employment, health and 
disability, education, barriers to public services, crime 
and living environment. Educational level was defined as 
up to basic education (to the age of 16 or completion 
of the UK General Certificate of Secondary Education 
or equivalent), further education (subsequent qualifica-
tions to the age of 18), undergraduate and postgraduate 
education.
Questionnaires asked participants to rate the impor-
tance of information domains on a 9- point Likert scale, 
ranging from 1 (‘not essential’) to 9 (‘absolutely essen-
tial’). Information domains considered not essential after 
round 1 were discarded (see Data analyses). In round 2, 
participants were provided with feedback from round 
1 in the form of their previous score for each domain 
and a mean score from their stakeholder group. Partic-
ipants then rescored each information domain on the 
9- point Likert scale, and the results used to determine 
which domains should be retained and presented in the 
consensus meetings.
Professionals were also asked to rate the importance of 
most domains to be included as trial outcome measures 
in a core outcome set, the results of which are published 
elsewhere.19 An example page from the questionnaire is 
presented in figure 1 to demonstrate how professionals 
were asked both questions simultaneously. Some informa-
tion did not have a corresponding trial outcome measure 
(eg, ‘expected in hospital experience’ or ‘family risk of 
bowel cancer’) and, in those instances, professionals were 
only asked to rate them as information. Patients were not 
asked separate questions about trial outcome measures 
because, based on feedback from the patient steering 
group, the two concepts were considered synonymous.
Phase 3: Face-to-face consensus meetings
Separate consensus meetings were held with profes-
sionals and patients. The professional consensus meeting 
was conducted at the Tripartite Colorectal Meeting 
(meeting of the Association of Coloproctology of Great 
Britain and Ireland, the American Society of Colon and 
Rectal Surgeons, the Royal Society of Medicine, Royal 
Australasian College of Surgeons, Colorectal Surgical 
Society of Australia and New Zealand and the European 
Society of Coloproctology) in Birmingham, UK, in 2014. 
The meeting was open to all members of international 
societies. The patient meeting was held in Bristol, UK, in 
2013. Attendees at this meeting were all from the UK and 
had completed the questionnaire surveys and responded 
to an invitation to attend a consensus meeting.
The retained information domains from the second 
survey were presented and discussed at the meetings. 
Anonymised voting took place to ask participants to 
vote each domain as either ‘In’, ‘Out’ or ‘Unsure’ using 
electronic keypads. Histograms and descriptive statistics 
were created for each domain during the meeting and 
displayed to the participants. Where consensus was not 
reached further discussion ensured and additional voting.
Sample size
There are no agreed methods to set the sample size 
for Delphi surveys or consensus meetings. Therefore, 
an opportunistic approach was used with the aim of 
obtaining approximately 100 respondents for each stake-
holder group for the survey and a smaller group in which 
discussion could take place in the consensus meetings.
Data analyses
Information domains rated between 7 and 9 by over 50%, 
and between 1 and 3 by less than 15%, of respondents in 
round 1 were retained for round 2. Information domains 
not meeting these criteria were discarded. Mean scores 
were calculated for each retained domain to form the 
feedback for Round 2. Round 2 domains were retained 
using stricter criteria (between 7 and 9 by over 70%, 
and between 1 and 3 by less than 15%, of respondents). 
There are no agreed methods for selecting cut- off criteria 
within Delphi studies,23 and therefore the criteria were 
selected after discussion with collaborators. Domains 
retained after round 2 were considered in the consensus 
meetings. Inclusion in the final CIS was determined at 
the professional consensus meeting by majority vote. 
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Figure 2 Summary of results.
Table 1 Participant characteristics
Clinical centres
Responders 
(n=63)
Non- 
responders 
(n=18)
Region (%)
  Northern England 14 (22) 5 (28)
  Midland 8 (13) 0
  South East England 22 (35) 10 (55)
  South West England 9 (14) 0
  Wales 10 (16) 3 (17)
Mean number of major 
colorectal resections (range)
117 (38–275) 90 (29–210)
Patients
Responders 
(n=97)
Non- responders 
(n=170)
Mean age (range) 64 (29–87) 68 (29–88)
Female (%) 41 (42) 95 (56)
Cancer site (%)
  Rectum/anus 33 (35) 55 (32)
  Left colon 34 (36) 46 (27)
  Right colon 30 (29) 60 (36)
  Unknown 9 (5)
IMD quintile (%)*
  1 5 (5) 27 (16)
  2 13 (13) 38 (23)
  3 20 (21) 24 (14)
  4 20 (21) 41 (24)
  5 39 (40) 23 (23)
Educational level (%)
  Basic 30 (32)
  Higher 34 (35)
  Undergraduate 16 (16)
  Postgraduate 6 (6)
  Not disclosed 11 (11)
Marital status (%)
  Single/divorced 17 (18)
  Married/cohabiting 73 (75)
  Widowed 7 (7)
Employment status (%)
  Employed 16 (17)
  Retired 58 (60)
  Seeking work 1 (1)
  Not working 
voluntarily
5 (5)
  Sickness leave 5 (5)
  Other 12 (12)
Continued
In the patient consensus meeting, two rounds of voting 
were conducted to ensure patients adequately under-
stood the domains. Domains that were voted for by 60% 
of patients were included in the CIS after initial voting. 
Those voted for by 40%–60% were brought forward for 
further discussion and those voted less than 40% were 
discarded. In the second round, domains that achieved 
a two- thirds majority were included. All information 
domains retained from either meetings were included in 
the final CIS. Patients considered important information 
for IC and trial outcomes to be synonymous. Results of 
the patient consensus meeting are therefore presented as 
part of the core outcome set and are not repeated here.19
Patient and public involvement
Patients collaborators were involved in developing the 
study design, categorising information from data sources 
into domains, designing the Delphi questionnaire using 
patient centred language, and interpreting the clinical 
significance of results.
reSultS
Phase 1: Domain generation
All data sources identified 1216 pieces of information on 
CRC surgery that were categorised into 98 domains. A 
summary of the results is presented in figure 2.
Phase 2: Delphi consensus process
A total of 63/81 (78%) CRC centres responded including 
90 surgeons and 8 specialist nurses (table 1). Centres 
represented all geographical regions of England and 
Wales, and caseload ranged from 38 to 275 operations 
per annum. Patient response rate was 97/267 (36%). The 
age range was wide, sex ratio equal and similar numbers 
of patients had rectal, left and right colonic tumours. 
Many patients lived in areas of low deprivation but there 
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Table 2 Voting on information domains to be included in 
the CIS in the surgeon consensus meetings
Information domain
Voted in 
(n=61)
ConsensusN (%)
Anastomotic leak 40 (65) In
Conversion to open operation 38 (63) In
Post- operative mortality 41 (62) In
DVT/PE 36 (59) In
Long- term survival 33 (54) In
Stoma formation 32 (53) In
Surgical site infection 30 (49) Out
Cancer recurrence 29 (48) Out
Reoperation 26 (43) Out
Haemorrhage 25 (41) Out
Sexual functioning 25 (41) Out
Global quality of life 24 (40) Out
Bowel obstruction 22 (37) Out
Faecal incontinence 20 (34) Out
Expected in- hospital 
experience
20 (34) Out
Visceral injury 18 (29) Out
Faecal urgency 18 (29) Out
Stoma complications 15 (25) Out
Physical functioning 12 (19) Out
Readmission 10 (17) Out
Abandoning the operation 10 (17) Out
Resection margins 2 (4) Out
Lymph node yield 2 (4) Out
CIS, core information set; DVT/PE, Deep venous 
thromboembolism/Pulmonary embolism.
Patients
Responders 
(n=97)
Non- responders 
(n=170)
Length of hospital stay 
(%)
  <2 weeks 80 (83)
  2–3 weeks 10 (10)
  3–4 weeks 3 (3)
  >4 weeks 4 (4)
*Index of Multiple Deprivation (IMD) as defined by the UK Office of 
National Statistics at lower layer Super Output Area level for the 
individual. Lower quintile equates to higher deprivation.
Table 1 Continued
was an even distribution of basic and higher educational 
level. Professionals rated information about short- term 
technical outcomes of greatest importance in round 
1 including anastomotic leak, adequacy of resection 
margins and perioperative mortality (online supplemen-
tary table 1). Although these issues were also important 
to patients, a priority was given to information about 
longer- term outcomes such as survival, distant recurrence 
and impact on quality of life. A total of 50 domains were 
retained for round 2.
The response rate in round 2 was 75% (78/104) for 
health professionals and 90% (87/97) for patients. The 
provision of feedback and more stringent cut- off criteria 
in round 2 resulted in 23 domains being retained for 
consideration in the consensus meetings.
Phase 3: Consensus meetings
The professional and patient consensus meetings were 
attended by 61 and 14 participants, respectively. Anony-
mised voting reached a consensus on six domains at the 
professionals meeting (table 2). In initial anonymised 
voting at the patient consensus meeting, 11 domains were 
voted ‘in’, three were voted ‘out’ and nine were incon-
clusive. Subsequently, domains that were recognised as 
overlapping were combined.19 ‘Length of hospital stay’ 
was broadened in scope to include all details of patients’ 
pathway through hospital such as the location of the 
hospital and ward, anticipated length of hospital stay and 
follow- up arrangements. This information domain was 
renamed ‘Expected in- hospital experiences’. A second 
round of voting reached a consensus on including three 
more domains into the CIS: ‘anastomotic leak’, ‘stoma 
complications’ and ‘sexual functioning’. Patient and 
professional CIS were then combined (box 1), creating a 
final list of 11 domains.
DISCuSSIOn
This study developed a CIS to inform consent for CRC 
surgery. A wide range of sources including published 
studies and patient interviews were used to identify the 
initial long- list of 100 information domains that could 
be communicated to patients. Established consensus 
methods were used to prioritise the views of patients 
and professionals to identify 23 domains of the greatest 
importance. Finally, consensus meetings with an inter-
national group of surgeons and UK patients agreed on 
the final CIS. It is recommended that the domains in the 
information set are discussed with all patients before CRC 
surgery as a baseline to improve patient understanding of 
expected events and outcomes of surgery and to catalyse 
questions relevant to the patient for further discussion.
Cancer patients’ information needs have been studied 
extensively.6 24 While these papers raise important issues, 
none have examined in detail the information both 
patients and professionals consider essential to commu-
nicate in advance of surgery for CRC. A systematic review 
identified 239 studies investigating the information needs 
of patients.24 It used a qualitative framework analysis to 
chart patients’ documented information needs across 
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box 1 Final core information set
Information about experiences in hospital
 ► Expected in- hospital experience including length of stay
 ► Perioperative survival
 ► Surgical site infection
 ► Venous thromboembolism
 ► Anastomotic leak
 ► Stomata and complications
 ► Conversion to open operation (where appropriate)
Information about experiences after discharge
 ► Cancer recurrence
 ► Resection margins
 ► Long- term survival
 ► Quality of life including physical and sexual function, faecal inconti-
nence and urgency
studies. ‘Treatment- related information’ was the most 
commonly documented need (561 mentions (26%) out 
of a total 2122 in 239 studies), of which information about 
‘risks and benefits of treatment’ was the most frequent. 
‘Rehabilitation information’ (384 (18%) mentions), 
specifically ‘stoma care’ was the next most frequently 
documented need. A Dutch cross sectional survey asked 
101 surgeons (response rate 43%) to rate the impor-
tance of 12 selected items of information about risks of 
anastomotic leak and stomata.25 Most surgeons reported 
to ‘always’ provide information about the risk of anasto-
motic leak (99%), reoperation (93%) and stoma (93%). 
It is not clear, however, how this questionnaire was devel-
oped, and the scope was limited when compared with the 
100 information domains included in this study. None-
theless, these results triangulate well with the findings of 
the CIS work presented here.
Although there are no published CISs in CRC surgery, a 
similar concept has been developed for patients undergoing 
radiotherapy for rectal cancer.26 A total of 37 information 
domains were identified through analysis of audio- recorded 
clinical consultations and systematic literature reviews. 
Delphi surveys and consensus meetings with groups of 
patients and radiation oncologists gained consensus on 13 
benefits and harms of treatment that should be discussed 
in consultations. Some of this information was found to 
have similar importance with surgeons and patients under-
going CRC surgery including information about local 
cancer control, survival, sexual and bowel function. Under-
standably, other information is unique to surgical therapy. 
Indeed a CIS has been developed for patients undergoing 
oesophagectomy12 which shares several characteristics with 
the colorectal CIS, such as recommending discussions 
about in- hospital mortality and major complications. Differ-
ences in quality of life information reflect the nature of the 
surgeries, with the colorectal CIS including issues of defeca-
tion, whereas the oesophageal CIS recommends discussing 
eating. In addition, patients and professionals agreed that 
discussing stomata was important before colorectal but not 
oesophageal surgery where oesophagostomy is infrequently 
required. It is possible that future CIS in other areas of 
surgical oncology will be developed and generic issues iden-
tified across the sets relevant to all patients with cancer.
Strengths and limitations
Robust consensus methodology and established guide-
lines modified from the development of core outcome 
sets for randomised trials were used to develop this CIS, 
but there are some weaknesses. The large amount of 
information identified in phase 1 required the grouping 
of information into domains. This introduces an element 
of subjectivity that was minimised through independent 
dual categorisation; however, information may have been 
inappropriately grouped or separated. For example, the 
Dutch CIS for rectal cancer radiotherapy recommended 
the discussion of five topics around sexual function that 
this study had combined into one domain.26 Of note, 
patients in this study had the opportunity to separate 
concepts out of domains in the consensus meetings but 
none chose to do so. Conversely, several domains were 
amalgamated where participants considered that they 
were unnecessarily detailed. In addition, patients were 
involved with the information categorisation process and 
agreed on the domains in advance of the Delphi process. 
In phase 2, the scope of the Delphi process was limited to 
the UK before the CIS development process was opened 
internationally to professionals in phase 3. This was done 
to exclude the least important information without the 
complexity of a multinational Delphi process, however 
different domains may have been brought forward 
for discussion at the consensus meetings if this were 
conducted. It will therefore be important to validate this 
set in other cultures.
There are no definitive guidelines on sample size and 
response rates for Delphi studies. The total number of 
participants in this study is comparatively high and there 
was a good representation of UK CRC surgical centres, but 
the response rates from patients was much lower. The effect 
of this on the validity of the Delphi is unclear because the 
methodology does not require a representative sample, but 
to gain a consensus among a wide range of individuals with 
disparate opinions. In that respect, this study achieved wide 
diversity based on a priori patient characteristics.
This study has identified an agreed minimum standard 
of information to be communicated before CRC surgery. 
Further research is now required to investigate methods to 
communicate this information effectively in routine prac-
tice. This may include agenda setting in clinical encoun-
ters,27 using visual communication aids28 29 or modifying 
hospital information leaflets to detail core information. 
Recent reviews of interventions to improve IC, however, 
showed that most were inadequately developed, without 
theory or conceptualisation.30 31 Included studies were 
poorly designed, susceptible to bias and outcome measures 
to assess interventions for IC were inconsistent. It will be 
necessary to pilot core information carefully, adhering to 
guidelines for the development of complex interventions,32 
to ensure it is ready for robust evaluation in a cluster 
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randomised trial. Further research is also needed to under-
stand how CISs relate back to modern professional, ethical 
and legal standards worldwide.
In conclusion, this study developed an evidence- based 
CIS to communicate to patients before CRC surgery. It 
is not intended to replace individualised discussions with 
patients, but to act as a consistent starting point to catalyse 
further patient- centred discussions. Core information can 
be communicated by any professional in any healthcare 
setting, and form the basis of high- quality written infor-
mation leaflets. This coordinated and reliable approach 
to information provision may help patients gain sufficient 
understanding to undergo surgery for CRC in a post Mont-
gomery era.
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